69 related articles for article (PubMed ID: 17551001)
1. LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling.
Li L; Naples M; Song H; Yuan R; Ye F; Shafi S; Adeli K; Ng DS
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E587-94. PubMed ID: 17551001
[TBL] [Abstract][Full Text] [Related]
2. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
[TBL] [Abstract][Full Text] [Related]
3. Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice.
Hager L; Li L; Pun H; Liu L; Hossain MA; Maguire GF; Naples M; Baker C; Magomedova L; Tam J; Adeli K; Cummins CL; Connelly PW; Ng DS
J Biol Chem; 2012 Jun; 287(24):20755-68. PubMed ID: 22500017
[TBL] [Abstract][Full Text] [Related]
4. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
5. Lecithin cholesterol acyltransferase null mice are protected from diet-induced obesity and insulin resistance in a gender-specific manner through multiple pathways.
Li L; Hossain MA; Sadat S; Hager L; Liu L; Tam L; Schroer S; Huogen L; Fantus IG; Connelly PW; Woo M; Ng DS
J Biol Chem; 2011 May; 286(20):17809-20. PubMed ID: 21454561
[TBL] [Abstract][Full Text] [Related]
6. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance.
Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW
J Biol Chem; 2004 Feb; 279(9):7636-42. PubMed ID: 14668345
[TBL] [Abstract][Full Text] [Related]
7. Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice.
Karavia EA; Papachristou DJ; Kotsikogianni I; Triantafyllidou IE; Kypreos KE
J Nutr Biochem; 2013 Mar; 24(3):567-77. PubMed ID: 22819565
[TBL] [Abstract][Full Text] [Related]
8. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress is markedly elevated in lecithin:cholesterol acyltransferase-deficient mice and is paradoxically reversed in the apolipoprotein E knockout background in association with a reduction in atherosclerosis.
Ng DS; Maguire GF; Wylie J; Ravandi A; Xuan W; Ahmed Z; Eskandarian M; Kuksis A; Connelly PW
J Biol Chem; 2002 Apr; 277(14):11715-20. PubMed ID: 11809774
[TBL] [Abstract][Full Text] [Related]
10. Lecithin:Cholesterol Acyltransferase (LCAT) Deficiency Promotes Differentiation of Satellite Cells to Brown Adipocytes in a Cholesterol-dependent Manner.
Nesan D; Tavallaee G; Koh D; Bashiri A; Abdin R; Ng DS
J Biol Chem; 2015 Dec; 290(51):30514-29. PubMed ID: 26494623
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.
Ueki K; Kondo T; Kahn CR
Mol Cell Biol; 2004 Jun; 24(12):5434-46. PubMed ID: 15169905
[TBL] [Abstract][Full Text] [Related]
12. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
13. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction.
Al-Regaiey KA; Masternak MM; Bonkowski M; Sun L; Bartke A
Endocrinology; 2005 Feb; 146(2):851-60. PubMed ID: 15498882
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
Vaziri ND; Liang K; Parks JS
Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
[TBL] [Abstract][Full Text] [Related]
15. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.
Koo SH; Satoh H; Herzig S; Lee CH; Hedrick S; Kulkarni R; Evans RM; Olefsky J; Montminy M
Nat Med; 2004 May; 10(5):530-4. PubMed ID: 15107844
[TBL] [Abstract][Full Text] [Related]
16. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM
Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
[TBL] [Abstract][Full Text] [Related]
17. Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling.
Cho CY; Koo SH; Wang Y; Callaway S; Hedrick S; Mak PA; Orth AP; Peters EC; Saez E; Montminy M; Schultz PG; Chanda SK
Cell Metab; 2006 May; 3(5):367-78. PubMed ID: 16679294
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
[TBL] [Abstract][Full Text] [Related]
19. The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
Guo S; Dunn SL; White MF
Mol Endocrinol; 2006 Dec; 20(12):3389-99. PubMed ID: 16916938
[TBL] [Abstract][Full Text] [Related]
20. Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro.
Leong GM; Moverare S; Brce J; Doyle N; Sjögren K; Dahlman-Wright K; Gustafsson JA; Ho KK; Ohlsson C; Leung KC
Endocrinology; 2004 Dec; 145(12):5525-31. PubMed ID: 15319356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
